目录号 | 产品详情 | 靶点 | |
---|---|---|---|
T1911 | ROCK Akt PKC | ||
Afuresertib (GSK2110183) 是一个选择性,ATP 竞争性,口服有效的泛 Akt 抑制剂,作用于 Akt1、Akt2和 Akt3,Ki 值分别为 0.08、2、2.6 nM。 | |||
T3518 | ROCK S6 Kinase | ||
GSK269962A (GSK269962A HCl) 是一种有效的ROCK 抑制剂,具有抗炎和血管舒张作用。它作用于重组人ROCK1和ROCK2,IC50分别为 1.6 和 4 nM。 | |||
T78205 | ROCK | ||
ROCK2-IN-6 hydrochloride (Comp A)为一种选择性ROCK2抑制剂,适用于研究ROCK介导的疾病、自身免疫性病症与炎症。 | |||
TQ0319 | ROCK | ||
Ripasudil (Ripasudil hydrochloride dihydrate) 是一种 ROCK 特异性抑制剂,能够抑制 ROCK1和 ROCK2的活性,IC50值分别为 51 和 19 nM。 | |||
T79832 | ROCK | ||
ROCK2-IN-6 (Comp A) 是一種选择性针对ROCK2的抑制剂,适用于研究ROCK介导的病症、自身免疫性疾病以及炎症。 | |||
T73117 | |||
ROCK2-IN-5是一种复合型化合物,融合了Rho激酶抑制剂fasudil以及NRF2诱导剂咖啡酸和阿魏酸的结构元素。该化合物展示了优秀的多靶点作用特性和较高的耐受性。ROCK2-IN-5在针对SOD1基因变异型ALS研究中具备应用潜力。 | |||
T81261 | ROCK | ||
ROCK2-IN-7是针对ROCK2的激酶抑制剂,能够抑制ROCK2/pSTAT3信号通路。该化合物在治疗银屑病模型中有着明显效果,通过抑制全身免疫激活,从而减轻炎症。 | |||
T1725 | ROCK Apoptosis | ||
Y-27632 dihydrochloride (Y-27632 2HCl) 是一种 ROCK-I 和 ROCK-II 抑制剂,具有口服有效性、ATP 竞争性。Y-27632 dihydrochloride 还抑制分离诱导的小鼠前列腺干或祖细胞凋亡。 | |||
T4276 | ROCK | ||
Hydroxyfasudil Hydrochloride (HA 1100 hydrochloride) 是一种ROCK 抑制剂,对ROCK1和ROCK2的IC50值分别为 0.73 和 0.72 μM。 | |||
T7552 | ROCK | ||
H-1152 是一种膜通透的选择性ROCK 抑制剂,Ki 为 1.6 nM,对ROCK2的IC50为 12 nM。 |
目录号 | 产品名/同用名 | 种属 | 表达系统 | ||
---|---|---|---|---|---|
TMPH-03265 | CMKLR2 Protein, Rat, Recombinant (His) | Rat | in vitro E. coli expression system | ||
Receptor for chemoattractant adipokine chemerin/RARRES2 suggesting a role for this receptor in the regulation of inflammation and energy homesotasis. Signals mainly via beta-arrestin pathway. Binding of RARRES2 activates weakly G proteins, calcium mobilization and MAPK1/MAPK3 (ERK1/2) phosphorylation too. Acts also as a receptor for TAFA1, mediates its effects on neuronal stem-cell proliferation and differentiation via the activation of ROCK/ERK and ROCK/STAT3 signaling pathway.
|
|||||
TMPH-01805 | ODAM Protein, Human, Recombinant (His) | Human | E. coli | ||
Tooth-associated epithelia protein that probably plays a role in odontogenesis, the complex process that results in the initiation and generation of the tooth. May be incorporated in the enamel matrix at the end of mineralization process. Involved in the induction of RHOA activity via interaction with ARHGEF and expression of downstream factors such as ROCK. Plays a role in attachment of the junctional epithelium to the tooth surface.
|
|||||
TMPH-02697 | GNA12 Protein, Mouse, Recombinant (His & Myc) | Mouse | E. coli | ||
Guanine nucleotide-binding proteins (G proteins) are involved as modulators or transducers in various transmembrane signaling systems. Activates effector molecule RhoA by binding and activating RhoGEFs (ARHGEF12/LARG). GNA12-dependent Rho signaling subsequently regulates transcription factor AP-1 (activating protein-1). GNA12-dependent Rho signaling also regulates protein phosphatese 2A activation causing dephosphorylation of its target proteins. Promotes tumor cell invasion and metastasis by activating RhoA/ROCK signaling pathway and up-regulating proinflammatory cytokine production. Inhibits CDH1-mediated cell adhesion in process independent from Rho activation. Together with NAPA promotes CDH5 localization to plasma membrane. May play a role in the control of cell migration through the TOR signaling cascade.
|